These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 9172951)
1. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat. Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951 [TBL] [Abstract][Full Text] [Related]
2. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat. Choudhury R; Singh S Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and pharmacokinetics of 1-(2'-hydroxy-ethyl)- and 1-(3'-hydroxypropyl)-2-ethyl-3-hydroxypyridin-4-ones in the rat. Singh S; Choudhury R; Epemolu RO; Hider RC Eur J Drug Metab Pharmacokinet; 1996; 21(1):33-41. PubMed ID: 8839676 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats. Epemolu OR; Singh S; Hider RC; Damani LA Drug Metab Dispos; 1992; 20(5):736-41. PubMed ID: 1358580 [TBL] [Abstract][Full Text] [Related]
5. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
7. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat. Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
9. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
10. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat. Zuo Z; Tam YK; Diakur J; Wiebe LI J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog. Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508 [TBL] [Abstract][Full Text] [Related]
14. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat. Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948 [TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
16. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice. Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218 [TBL] [Abstract][Full Text] [Related]
17. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats. Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Cook CS; Karim A; Sollman P Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of representative 3-hydroxypyridin-4-ones in rabbits: CP20 and CP94. Fredenburg AM; Wedlund PJ; Skinner TL; Damani LA; Hider RC; Yokel RA Drug Metab Dispos; 1993; 21(2):255-8. PubMed ID: 8097694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]